Welcome to the Ulcerative Colitis Resource Center, brought to you by Healio.com/Gastroenterology. Here you'll find the latest information on the diagnosis, management and treatment of ulcerative colitis, as well as up-to-date material on future research. Be sure to check out Healio.com/Gastroenterology for more news and perspective important to your practice.
January 8, 2019
Etrasimod — an oral, selective sphingosine 1 phosphate receptor modulator — demonstrated durable clinical remission in the treatment of…
In the Journals
December 31, 2018
Physicians should be careful when prescribing immunomodulator therapy to patients with inflammatory bowel disease who have higher comorbid status…
In the Journals
December 27, 2018
Antidepressants could be a beneficial therapy for patients with inflammatory bowel disease for symptoms beyond anxiety and depression, according to…
December 8, 2018
Target PharmaSolutions has announced a strategic partnership with Bristol-Myers Squibb to conduct a longitudinal observational study that will…
December 4, 2018
December 1 to December 7 marks Crohn’s & Colitis Awareness Week. First created by U.S. Senate Resolution 199 in November 2011, this…
In the Journals
December 3, 2018
A single visit with a consultant helped improve vaccination knowledge and coverage among patients with inflammatory bowel disease or gastrointestinal…
November 30, 2018
OSE Immunotherapeutics has received authorization to initiate a phase 1 clinical trial of OSE-127, a monoclonal antibody targeting the IL-7 receptor…
In the Journals
November 29, 2018
Xeljanz — a small-molecule Janus kinase inhibitor — appeared safe for the treatment of patients with moderate-to-severe ulcerative…
In the Journals
November 26, 2018
Abrilumab, an anti-alpha-4 beta-7 antibody, helped induce remission, clinical response and mucosal healing in patients with moderate to severe…